1. Home
  2. ACXP vs PMAX Comparison

ACXP vs PMAX Comparison

Compare ACXP & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$3.22

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Logo Powell Max Limited

PMAX

Powell Max Limited

BUY

Current Price

$3.28

Market Cap

4.5M

Sector

N/A

ML Signal

BUY

Company Overview

Basic Information
Metric
ACXP
PMAX
Founded
2017
2019
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8M
4.5M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
ACXP
PMAX
Price
$3.22
$3.28
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$143.67
N/A
AVG Volume (30 Days)
51.4K
1.6M
Earning Date
11-12-2025
09-23-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,799,100.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.17
$1.56
52 Week High
$25.00
$25.44

Technical Indicators

Market Signals
Indicator
ACXP
PMAX
Relative Strength Index (RSI) 32.54 74.38
Support Level $3.17 $1.56
Resistance Level $3.50 $3.04
Average True Range (ATR) 0.35 0.29
MACD -0.06 0.16
Stochastic Oscillator 2.62 97.77

Price Performance

Historical Comparison
ACXP
PMAX

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About PMAX Powell Max Limited

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

Share on Social Networks: